{
    "@text": "Is Myocardial infarction treated with the medication Labetalol and a Kazal-type serine protease inhibitor domain?",
    "@confidence": "0.5",
    "@support": "0",
    "@types": "",
    "@sparql": "",
    "@policy": "whitelist",
    "Resources": [
        {
            "@URI": "http://dbpedia.org/resource/Infarction",
            "@support": "454",
            "@types": "Wikidata:Q12136,DBpedia:Disease",
            "@surfaceForm": "infarction",
            "@offset": "14",
            "@similarityScore": "0.9933619506060432",
            "@percentageOfSecondRank": "0.00544536394551586"
        },
        {
            "@URI": "http://dbpedia.org/resource/Labetalol",
            "@support": "67",
            "@types": "Wikidata:Q8386,DUL:ChemicalObject,DBpedia:Drug,DBpedia:ChemicalSubstance",
            "@surfaceForm": "Labetalol",
            "@offset": "53",
            "@similarityScore": "0.999999999968253",
            "@percentageOfSecondRank": "0.0"
        },
        {
            "@URI": "http://dbpedia.org/resource/Kazal_domain",
            "@support": "7",
            "@types": "Wikidata:Q8054,Wikidata:Q206229,DBpedia:Protein,DBpedia:Biomolecule",
            "@surfaceForm": "Kazal-type serine protease inhibitor domain",
            "@offset": "69",
            "@similarityScore": "1.0",
            "@percentageOfSecondRank": "0.0"
        }
    ]
}